Chris Brinsmead joins the Board of Kinapse
Published date:
05/10/2010
London, UK
The Board of Directors of Kinapse Ltd. is delighted to announce that Chris Brinsmead has agreed to become a Non-Executive Director of Kinapse. Chris has had a long and distinguished career in the pharmaceutical industry, notably with Astra Zeneca where he was the President of their UK business. He has also recently served as President of the Association of the British Pharmaceutical Industry (ABPI).
Nick Edwards, Chairman of Kinapse Ltd., said, “I am delighted that Chris has agreed to join the Board of Kinapse. He will bring an extremely valuable perspective to our leadership of the business. We all look forward to working with him as Kinapse pursues its aggressive growth agenda.”
Kinapse Ltd.
About Kinapse
Kinapse provides consulting and outsourcing services to the global life sciences industries.
Our clients include many of the world’s leading pharmaceutical, biotechnology, medical device and specialty pharmaceutical companies, government organisations and life sciences service providers.
Kinapse specialises in addressing the challenges of life sciences. We understand the complex issues faced throughout the life sciences value chain and offer innovative insights, advice and service delivery to our clients.
Contact:
info@kinapse.com, +44 (0)208 946 7600
Mission Statement
InPharm.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma jobs, pharma events, and pharma service company listings.
Site content is produced by our editorial team for InPharm.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
